Association of stem cell marker CD133 expression with dissemination of glioblastomasTakamasa Kayama, Atsushi Satō, Kaori Sakurada et al.|Neurosurgical Review|2010Cited by 33
Treatment outcomes in glioblastoma patients aged 76 years or older: a multicenter retrospective cohort studyTakamasa Kayama, Takeo Uzuka, Kenichiro Asano et al.|Journal of Neuro-Oncology|2013Cited by 18
Molecular Features and Prognostic Factors of Pleomorphic Xanthoastrocytoma: A Collaborative Investigation of the Tohoku Brain Tumor Study GroupTakahiro Ono, Toshio Sasajima, Hiroaki Shimizu et al.|Neurologia medico-chirurgica|2020Cited by 11
Clinicopathological risk factors for a poor prognosis of primary central nervous system lymphoma in elderly patients in the Tohoku and Niigata area: a multicenter, retrospective, cohort study of the Tohoku Brain Tumor Study GroupKenichiro Asano, Teiji Tominaga, Yoji Yamashita et al.|Brain Tumor Pathology|2022Cited by 6
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study GroupKenichiro Asano, Teiji Tominaga, Yoji Yamashita et al.|International Journal of Clinical Oncology|2021Cited by 6